SmallCap
CompaniesStatistics

(주)비엔에이치리서치

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)비엔에이치리서치
Business Reg. No.2038165649
CEO정승수
Address강원 춘천시
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products신약개발 및 약물효능평가 서비스
EstablishedContact
Phone704-366-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.285011-*******

Investment Metrics


Market Cap
-
Op. Margin
-
ROE
-853.16%
Debt Ratio
328.43%

Certification Status


Venture Certified

Cert. History
기술평가대출기업(중진공)2016-06-02 ~ 2018-06-01201604008632016-06-02
기술평가보증기업(기금)2018-06-02 ~ 2020-06-01201801063822016-06-02
기술평가보증기업(기금)2020-06-02 ~ 2022-06-01202001070952016-06-02
벤처투자유형2022-06-02 ~ 2025-06-01202205180100072016-06-02
벤처투자유형2025-06-02 ~ 2028-06-01202505130100162016-06-02

Financial Statements


3-Year Financial Data

Revenue CAGR -54.9%

Item202420232022
Revenue

0.0B

0.6B

1.2B

Operating Profit

-36.3B

-64.5B

-38.3B

Net Profit

-36.9B

-64.9B

-38.5B

Total Assets

18.5B

43.2B

108.5B

Total Liabilities

14.2B

12.0B

13.1B

Total Equity

4.3B

31.2B

95.4B

Risk Indicators


4 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
0

100.0%

vs. 3-Year Avg.: 885010K
Operating Profit
-36B

29.5%

vs. 3-Year Avg.: -51B
Debt Ratio
328.4%

1157.5%

vs. 3-Year Avg.: 26.1%
ROE
-853.2%

587.1%

vs. 3-Year Avg.: -124.2%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
정승수대표이사대표

Employment Status


Regular EmployeesContact
CEO정승수

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "강원 춘천시",
  "ceo_name": "정승수",
  "certificate": [
    {
      "cert_number": "20160400863",
      "changes": "",
      "disclosure_date": "2016-06-02",
      "first_cert_date": "2016-06-02",
      "no": "1",
      "type": "기술평가대출기업(중진공)",
      "valid_period": "2016-06-02 ~ 2018-06-01"
    },
    {
      "cert_number": "20180106382",
      "changes": "",
      "disclosure_date": "2018-05-28",
      "first_cert_date": "2016-06-02",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-06-02 ~ 2020-06-01"
    },
    {
      "cert_number": "20200107095",
      "changes": "",
      "disclosure_date": "2020-05-29",
      "first_cert_date": "2016-06-02",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-06-02 ~ 2022-06-01"
    },
    {
      "cert_number": "20220518010007",
      "changes": "",
      "disclosure_date": "2022-05-18",
      "first_cert_date": "2016-06-02",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-06-02 ~ 2025-06-01"
    },
    {
      "cert_number": "20250513010016",
      "changes": "",
      "disclosure_date": "2025-05-13",
      "first_cert_date": "2016-06-02",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-06-02 ~ 2028-06-01"
    }
  ],
  "company_name": "(주)비엔에이치리서치",
  "corp_no": "285011-*******",
  "financials": {
    "2022": {
      "capital_stock": 107719000,
      "cost_of_sales": 0,
      "current_assets": 9224906000,
      "current_liabilities": 1307941000,
      "gross_profit": 122000000,
      "net_income": -3846519000,
      "net_income_bs": -3846520000,
      "non_current_assets": 1626090000,
      "non_current_liabilities": 5540000,
      "non_operating_expenses": 47118000,
      "non_operating_income": 32221000,
      "operating_profit": -3831622000,
      "revenue": 122000000,
      "sga_expenses": 3953622000,
      "total_assets": 10850995000,
      "total_equity": 9537514000,
      "total_liabilities": 1313481000
    },
    "2023": {
      "capital_stock": 108806000,
      "cost_of_sales": 0,
      "current_assets": 2779387000,
      "current_liabilities": 1200556000,
      "gross_profit": 55000000,
      "net_income": -6493120000,
      "net_income_bs": -6493120000,
      "non_current_assets": 1542558000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 61249000,
      "non_operating_income": 16777000,
      "operating_profit": -6448648000,
      "revenue": 55000000,
      "sga_expenses": 6503648000,
      "total_assets": 4321945000,
      "total_equity": 3121389000,
      "total_liabilities": 1200556000
    },
    "2024": {
      "capital_stock": 110561000,
      "cost_of_sales": 0,
      "current_assets": 443198000,
      "current_liabilities": 1420019000,
      "gross_profit": 0,
      "net_income": -3688733000,
      "net_income_bs": -3688733000,
      "non_current_assets": 1409182000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 64880000,
      "non_operating_income": 1884000,
      "operating_profit": -3625737000,
      "revenue": 0,
      "sga_expenses": 3625737000,
      "total_assets": 1852380000,
      "total_equity": 432361000,
      "total_liabilities": 1420019000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,000,139,100",
      "changes": "2,000,139,100",
      "date": "2024-05-23"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2022-03-18"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2022-03-18"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2022-03-18"
    },
    {
      "amount": "3,000,000,000",
      "changes": "3,000,000,000",
      "date": "2022-03-18"
    },
    {
      "amount": "3,000,000,000",
      "changes": "3,000,000,000",
      "date": "2022-03-18"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2020-05-26"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2020-05-26"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2020-05-13"
    },
    {
      "amount": "200,000,000",
      "changes": "200,000,000",
      "date": "2019-03-29"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2017-04-26"
    }
  ],
  "main_products": "신약개발 및 약물효능평가 서비스",
  "phone": "704-366-****",
  "years": [
    2024,
    2023,
    2022
  ]
}